World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Genetics
USA
2026

D-Index & Metrics

Best Scientists

D-Index
290
Citations
495255
World Ranking
18
National Ranking
13

Genetics

D-Index
288
Citations
479775
World Ranking
2
National Ranking
2

Medicine

D-Index
291
Citations
499329
World Ranking
10
National Ranking
9

Research.com Recognitions

  • 2026 - Research.com Genetics in United States Leader Award
  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Genetics in United States Leader Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2024 - Research.com Genetics in United States Leader Award
  • 2024 - Research.com Genetics and Molecular Biology in United States Leader Award
  • 2023 - Research.com Genetics in United States Leader Award
  • 2023 - Research.com Medicine in United States Leader Award
  • 2022 - Research.com Genetics and Molecular Biology in United States Leader Award
  • 2021 - Japan Prize for their pioneering work in conceptualizing a multi-step model of carcinogenesis and its application and impact on improving cancer diagnosis and therapy.
  • 2020 - Jessie Stevenson Kovalenko Medal, US National Academy of Sciences For his pioneering work in elucidating the fundamental principles of the molecular basis of human cancer and the application of this knowledge to improve the clinical management of patients.
  • 2019 - Albany Medical Center Prize in Medicine and Biomedical Research
  • 2019 - Gruber Prize in Genetics
  • 2015 - Dr. Paul Janssen Award for Biomedical Research, Johnson & Johnson for his breakthroughs in oncology research.
  • 2015 - Fellow, National Academy of Inventors
  • 2013 - Breakthrough Prize in Life Sciences for cancer genomics and tumor suppressor genes.
  • 2007 - Robert J. and Claire Pasarow Foundation Medical Research Award
  • 2006 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2001 - Member of the National Academy of Medicine (NAM)
  • 2000 - Charles S. Mott Prize, General Motors Cancer Research Foundation
  • 1998 - Paul Ehrlich and Ludwig Darmstaedter Prize
  • 1998 - Louisa Gross Horwitz Prize, Columbia University
  • 1998 - William Allan Award, the American Society of Human Genetics
  • 1997 - William Beaumont Prize, American Gastroenterological Association (AGA)
  • 1992 - Member of the National Academy of Sciences
  • 1992 - Fellow of the American Academy of Arts and Sciences
  • 1992 - Canada Gairdner International Award
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Bert Vogelstein is affiliated with Johns Hopkins University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with notable focus on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Pathology and Forensic Medicine.

The main topics of Vogelstein's work include:

  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • Pancreatic and Hepatic Oncology Research
  • Immunotherapy and Immune Responses
  • Epigenetics and DNA Methylation

Frequent publication venues for this researcher are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Clinical Oncology
  • eLife
  • Proceedings of the National Academy of Sciences
  • Cancer Research

Some recent papers include:

  • "Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer" (2022) published in New England Journal of Medicine
  • "Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention" (2020) published in Science
  • "Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers" (2021) published in Nature
  • "Targeting a neoantigen derived from a common TP53 mutation" (2021) published in Science
  • "Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study" (2021) published in PLoS Medicine

Frequently collaborating co-authors include:

  • Kenneth W. Kinzler
  • Nickolas Papadopoulos
  • Chetan Bettegowda
  • Shibin Zhou
  • Maria Popoli

Bert Vogelstein has received numerous awards throughout their career. These include:

  • Japan Prize (2021) for pioneering work in conceptualizing a multi-step model of carcinogenesis and its application in cancer diagnosis and therapy
  • Jessie Stevenson Kovalenko Medal, US National Academy of Sciences (2020) for elucidating fundamental principles of the molecular basis of human cancer and improving clinical management
  • Gruber Prize in Genetics (2019)
  • Albany Medical Center Prize in Medicine and Biomedical Research (2019)
  • Fellow of the National Academy of Inventors (2015)
  • Dr. Paul Janssen Award for Biomedical Research, Johnson & Johnson (2015) for breakthroughs in oncology research
  • Breakthrough Prize in Life Sciences (2013) for cancer genomics and tumor suppressor genes
  • Robert J. and Claire Pasarow Foundation Medical Research Award (2007)
  • Fellow of the American Association for the Advancement of Science (2006)
  • Member of the National Academy of Medicine (2001)
  • Charles S. Mott Prize, General Motors Cancer Research Foundation (2000)
  • Louisa Gross Horwitz Prize, Columbia University (1998)
  • William Allan Award, the American Society of Human Genetics (1998)
  • Paul Ehrlich and Ludwig Darmstaedter Prize (1998)
  • William Beaumont Prize, American Gastroenterological Association (1997)
  • Fellow of the American Academy of Arts and Sciences (1992)
  • Canada Gairdner International Award (1992)
  • Member of the National Academy of Sciences (1992)
  • Member of the Association of American Physicians

Best Publications

  • A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

    Andrew P. Feinberg;Bert Vogelstein

  • A genetic model for colorectal tumorigenesis

    Eric R. Fearon;Bert Vogelstein

  • WAF1, a potential mediator of p53 tumor suppression

    Wafik S. El-Deiry;Takashi Tokino;Victor E. Velculescu;Daniel B. Levy

  • p53 mutations in human cancers

    Monica Hollstein;David Sidransky;Bert Vogelstein;Curtis C. Harris

  • PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

    Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne R. Bartlett

  • Genetic alterations during colorectal-tumor development.

    Bert Vogelstein;Eric R. Fearon;Stanley R. Hamilton;Scott E. Kern

  • Surfing the p53 network

    Bert Vogelstein;David Lane;Arnold J. Levine

  • Cancer Genome Landscapes

    Bert Vogelstein;Nickolas Papadopoulos;Victor E. Velculescu;Shibin Zhou

  • Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

    Dung T. Le;Dung T. Le;Jennifer N. Durham;Jennifer N. Durham;Kellie N. Smith;Hao Wang

  • An Integrated Genomic Analysis of Human Glioblastoma Multiforme

    D. Williams Parsons;Siân Jones;Xiaosong Zhang;Jimmy Cheng-Ho Lin

  • Lessons from Hereditary Colorectal Cancer

    Kenneth W Kinzler;Bert Vogelstein;Bert Vogelstein

  • Serial analysis of gene expression

    Kenneth W Kinzler;Victor E Velvulescu;Bert Vogelstein;Lin Zhang

  • IDH1 and IDH2 Mutations in Gliomas

    Hai Yan;D. Williams Parsons;Genglin Jin;Roger McLendon

  • Identification of c-MYC as a Target of the APC Pathway

    Tong Chuan He;Andrew B. Sparks;Carlo Rago;Heiko Hermeking

  • Cancer genes and the pathways they control.

    Bert Vogelstein;Kenneth W Kinzler

  • Genetic instabilities in human cancers

    Christoph Lengauer;Kenneth W. Kinzler;Bert Vogelstein

  • Participation of p53 Protein in the Cellular Response to DNA Damage

    Michael B. Kastan;Onyinye Onyekwere;David Sidransky;Bert Vogelstein

  • Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

    Patrice J. Morin;Andrew B. Sparks;Vladimir Korinek;Nick Barker

  • Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

    Siân Jones;Xiaosong Zhang;D. Williams Parsons;D. Williams Parsons;Jimmy Cheng Ho Lin

  • Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    Chetan Bettegowda;Chetan Bettegowda;Mark Sausen;Rebecca J. Leary;Isaac Kinde

Frequent Co-Authors

Kenneth W. Kinzler
Kenneth W. Kinzler Johns Hopkins University
Nickolas Papadopoulos
Nickolas Papadopoulos Johns Hopkins University School of Medicine
Victor E. Velculescu
Victor E. Velculescu Johns Hopkins University School of Medicine
Luis A. Diaz
Luis A. Diaz Memorial Sloan Kettering Cancer Center
Ralph H. Hruban
Ralph H. Hruban Johns Hopkins University School of Medicine
Stanley R. Hamilton
Stanley R. Hamilton City Of Hope National Medical Center
Christoph Lengauer
Christoph Lengauer Johns Hopkins University
Sanford D. Markowitz
Sanford D. Markowitz Case Western Reserve University
Darell D. Bigner
Darell D. Bigner Duke University
Laura D. Wood
Laura D. Wood Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in genetics opens doors to many healthcare careers. Many professionals considering a future in medical genetics or research also explore advanced nursing roles. Flexible online options make it easier for working students to enter or advance in these fields without putting their lives on hold.

For those interested in the intersection between genetics and direct patient care, pursuing a nurse practitioner degree online is a popular pathway. It offers the opportunity to influence patient outcomes in specialties like genetic counseling or precision medicine. Students focused on value may compare low cost nursing programs to keep their studies affordable.

Those already holding a BSN can look at the most affordable bsn to dnp programs online to reach top clinical and leadership positions or contribute to genetics-focused healthcare research. Registered nurses wanting to advance academically and professionally might consider accessible rn to bsn programs.

Blending studies in genetics with advanced nursing skills can greatly expand your career pathways and impact in the rapidly changing healthcare landscape.

Best Scientists Citing Bert Vogelstein

Trending Scientists

Recently Published Articles